Next report date
Report period
H2 2024
EPS estimate
—
Revenue estimate
—
−0.023AUD
−5.06 MAUD
About BCAL DIAGNOSTICS LIMITED
Sector
Industry
CEO
Shane Ryan
Website
Headquarters
Sydney
Founded
2010
ISIN
AU0000160921
FIGI
BBG011N6JC91
BCAL Diagnostics Ltd. develops screening tests for the early detection of breast cancer. It also associated lipids, biomarker blood test that is used for prevention, screening and monitoring. The company was founded by Jayne Shaw and Ron Philips in 2010 and is headquartered in Sydney, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BDX is 0.092 AUD — it has decreased by 3.16% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange BCAL DIAGNOSTICS LIMITED stocks are traded under the ticker BDX.
BCAL DIAGNOSTICS LIMITED is going to release the next earnings report on Aug 27, 2024. Keep track of upcoming events with our Earnings Calendar.
BDX stock is 3.26% volatile and has beta coefficient of −0.76. Check out the list of the most volatile stocks — is BCAL DIAGNOSTICS LIMITED there?
Yes, you can track BCAL DIAGNOSTICS LIMITED financials in yearly and quarterly reports right on TradingView.
BDX stock has fallen by 8.00% compared to the previous week, the month change is a 12.38% fall, over the last year BCAL DIAGNOSTICS LIMITED has showed a 2.22% increase.
BDX net income for the last quarter is −2.41 M AUD, while the quarter before that showed −2.59 M AUD of net income which accounts for 7.11% change. Track more BCAL DIAGNOSTICS LIMITED financial stats to get the full picture.
No, BDX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BDX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BCAL DIAGNOSTICS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BCAL DIAGNOSTICS LIMITED technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BCAL DIAGNOSTICS LIMITED stock shows the sell signal. See more of BCAL DIAGNOSTICS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.